Sample
traumatic brain injury, stroke, cancer, learning disability, dementia, bipolar disorder, psychosis, Alzheimer's disease or Parkinson's disease, schizophrenia, substance abuse
BREAST CANCER, STROKE, DISEASE, CANCER, INVASIVE CANCER, BASAL CELL SKIN CANCER
To be eligible for the original study, BCS were 21 years of age and older, had received chemotherapy as part of their adjuvant therapy for Stage 1–IIIA breast cancer, were ≥1‐year post‐adjuvant therapy (not including estrogen blocking therapy), and were disease free. For enrollment in the randomized controlled trial, all BCS had to report cognitive concerns (yes/no) and interest in receiving treatment for their cognitive concerns. In addition, all BCS in this study had fully completed the double‐masked randomized controlled trial testing computerized cognitive training against computerized global stimulating‐based games for improving CRCI.BCS excluded from the original study had history of or current diagnosis that would directly impact cognitive function including stroke, traumatic brain injury, dementia, Alzheimer's disease or Parkinson's disease, history of or current other cancer (except for basal cell skin cancer), or history of invasive cancer treatments (brain surgery, history of cranial radiation or intrathecal therapy). In addition, BCS with current active major depression, substance abuse, history of bipolar disorder, psychosis, schizophrenia, or learning disability or participating in any other training were also excluded.